Annual Report, Financials, and Strategic Plan
Our Annual Report
Our most recent annual report details our fiscal year from January 1, 2016 to December 31, 2016, including information on our research activities, finances, and staff.
Our Financials: Financial Statements and Reports of Independent Certified Public Accountants
More than 80 cents of every dollar the Crohn's & Colitis Foundation spends goes to research, education, and support services. The Foundation meets the standards of the Better Business Bureau's Wise Giving Alliance, and has received an "A" rating from the American Institute of Philanthropy. CCFA is also listed at Guidestar.
In addition, here are the financial statements and reports of independent certified public accountants for the Foundation's fiscal year 2016 (January 1, 2016-December 31, 2016). Our IRS Form 990 for 2016 is available here.
Our 2017-2019 Strategic Plan
Since 1967, the Crohn's & Colitis Foundation has led the way in research, advocacy, and patient support for those suffering from Crohn's disease and ulcerative colitis. Through the vision of our founders, Irwin and Suzanne Rosenthal, William and Shelby Modell, and Dr. Henry Janowitz, the Foundation has become the national beacon of hope for those suffering with inflammatory bowel diseases.
2017 is a big year for the Crohn's & Colitis Foundation. It's our 50th anniversary, and a great opportunity to celebrate past achievements. Perhaps even more important, this year we're launching a new brand and a new three-year strategic plan, the result of an in-depth, organization-wide process that represents vital input from patients and caregivers, as well as informed insights and months of research and planning by all of our key constituencies. This Plan is critical, because it lays out not just what we must accomplish from 2017 to 2019, but what we want to be, for and within the IBD community.
With our new Strategic Plan to guide our activities, and a new brand to more fully engage and inspire our constituents, we embark on the next three years with confidence and a renewed passion for realizing our vision -- to create a future free of Crohn's disease and ulcerative colitis.